Upgrades/Downgrades
Updated: 20-Nov-24 16:30 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Aclaris Therapeutics | ACRS | Cantor Fitzgerald | Neutral » Overweight | ||
| Logitech Int'l SA | LOGI | UBS | Sell » Neutral | ||
| SolarEdge Technologies | SEDG | Guggenheim | Sell » Neutral | ||
| Newell Brands | NWL | Barclays | Equal Weight » Overweight | $8 » $10 | |
| Lemonade | LMND | Morgan Stanley | Underweight » Equal-Weight | $23 » $42 | |
| Inspire Medical Systems | INSP | BofA Securities | Neutral » Buy | $220 » $255 | |
| Gaming and Leisure Properties | GLPI | Deutsche Bank | Hold » Buy | $49 » $54 | |
| Equinor | EQNR | Redburn Atlantic | Neutral » Buy | ||
| Energizer | ENR | JP Morgan | Underweight » Neutral | $32 » $39 | |
| Chewy | CHWY | BofA Securities | Underperform » Buy | $24 » $40 | |
| AstraZeneca | AZN | UBS | Sell » Neutral | ||
| AeroVironment | AVAV | Jefferies | Hold » Buy | $240 » $230 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Target | TGT | HSBC Securities | Buy » Hold | $138 | |
| NIO | NIO | Macquarie | Outperform » Neutral | $6.60 » $4.80 | |
| Danimer Scientific | DNMR | Piper Sandler | Neutral » Underweight | $40 » $4 | |
| Jacobs Solutions | J | The Benchmark Company | Buy » Hold | ||
| Target | TGT | Deutsche Bank | Buy » Hold | $108 | |
| Piedmont Lithium | PLL | ROTH MKM | Buy » Neutral | $32 » $13 | |
| Target | TGT | Citigroup | Buy » Neutral | $130 | |
| Toast | TOST | Exane BNP Paribas | Outperform » Neutral | $37 | |
| Block | SQ | Exane BNP Paribas | Outperform » Neutral | $88 | |
| Oaktree Specialty Lending Corp | OCSL | JP Morgan | Overweight » Neutral | $17 » $15 | |
| Northern Oil & Gas | NOG | RBC Capital Mkts | Outperform » Sector Perform | $43 » $45 | |
| JPMorgan Chase | JPM | Oppenheimer | Outperform » Perform | ||
| Galapagos NV | GLPG | Kepler | Hold » Reduce | ||
| Finance of America | FOA | UBS | Buy » Neutral | $14 » $24 | |
| Fannie Mae | FNMA | Keefe Bruyette | Outperform » Mkt Perform | $2 » $3 | |
| Fabrinet | FN | B. Riley Securities | Neutral » Sell | $194 » $178 | |
| Freddie Mac | FMCC | Keefe Bruyette | Outperform » Mkt Perform | $2.50 » $4 | |
| Fidelity Nat'l Info | FIS | Exane BNP Paribas | Neutral » Underperform | ||
| Energizer | ENR | Barclays | Overweight » Equal Weight | $34 » $36 | |
| DMC Global | BOOM | Stifel | Buy » Hold | $16 » $8 | |
| Bloom Energy | BE | HSBC Securities | Buy » Hold | $24.50 | |
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Talkspace | TALK | Northland Capital | Outperform | $5 | |
| Greif | GEF | Sidoti | Buy | $93 | |
| SpringWorks Therapeutics | SWTX | Evercore ISI | Outperform | $60 | |
| Toast | TOST | Compass Point | Buy | $49 | |
| Tectonic Therapeutic | TECX | Raymond James | Outperform | $65 | |
| Ingram Micro Holding Corp. | INGM | JP Morgan | Neutral | $28 | |
| GlobalFoundries | GFS | UBS | Neutral | $47 | |
| Fidelity Nat'l Info | FIS | Compass Point | Buy | $126 | |
| Fiserv | FI | Compass Point | Buy | $278 | |
| CAVA Group | CAVA | Bernstein | Mkt Perform | $145 | |
| AppLovin | APP | Piper Sandler | Overweight | $400 | |
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Tapestry | TPR | Barclays | Equal Weight | $57 | |
| First Advantage Corp. | FA | Barclays | Overweight | $22 | |
| Capri Holdings | CPRI | Barclays | Equal Weight | $21 | |
|
|
|||||
| Coverage Reiterated/Price Tgt Changed* | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Walmart | WMT | Telsey Advisory Group | Outperform | $92 » $100 | |
| Netflix | NFLX | Pivotal Research Group | Buy | $925 » $1100 | |
| PureCycle Technologies | PCT | TD Cowen | Buy | $10 » $15 | |
| Sky Harbour | SKYH | Maxim Group | Buy | $17 » $25 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |